|
市場調査レポート
商品コード
1455143
ヒアルロン酸ベースの皮膚フィラーの世界市場規模、シェア、成長分析、製品タイプ別、用途別 - 産業別予測、2024年～2031年Global Hyaluronic Acid Based Dermal Fillers Market Size, Share, Growth Analysis, By Product Type(Single phase and duplex products), By Application(Wrinkle correction, lip augmentation) - Industry Forecast 2024-2031 |
||||||
|
|
|||||||
|
|||||||
| ヒアルロン酸ベースの皮膚フィラーの世界市場規模、シェア、成長分析、製品タイプ別、用途別 - 産業別予測、2024年～2031年 |
|
出版日: 2024年03月19日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
ヒアルロン酸ベースの皮膚フィラーの世界市場規模は、2022年に42億2,000万米ドルと評価され、2023年の46億米ドルから2031年には94億2,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは9.10%で推移する見通しです。
美容分野におけるヒアルロン酸（HA）の多様な用途に対する認識の高まりと相まって、非侵襲的な美容施術に対する需要の急増が市場拡大を後押ししています。この動向は、革新的な真皮製品の研究開発への投資の増加や、加齢による外見への影響をますます気にするようになった男性の間で美容施術の傾向が高まっていることによって、さらに強化されています。2021年のレーザーリサーフェシング治療の導入に代表される技術の進歩は、非侵襲的技術への需要を満たしながら、様々な肌悩みに対する効率的な解決策を低侵襲で提供することで、状況を一変させています。市場リーダーは競争力を維持するために先進的なソリューションの開発を優先しており、しわやほうれい線の減少を目的とした画期的な皮膚フィラーであるRHA Redensityの最近のFDA承認など、新製品の承認が急増しています。しかしながら、米国、欧州連合などのような主要市場における厳しい政府規制は、HAベースの製品の開発、ブランド化、生産を規制する課題となっています。しかしながら、このような障害にもかかわらず、世界市場は、美容的処置に対する需要の増加と進行中の技術革新に後押しされ、大きな成長を遂げようとしています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
ヒアルロン酸ベースの皮膚フィラーの世界市場：製品タイプ別
- 市場概要
- 単相および二相製品
ヒアルロン酸ベースの皮膚フィラーの世界市場：用途別
- 市場概要
- しわ補正
- 口唇増大
- 鼻整形など
ヒアルロン酸ベースの皮膚フィラーの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Allergan（US）
- Galderma Laboratories L.P.（Switzerland）
- Merz Pharmaceuticals（Germany）
- Genzyme Corporation（US）
- Anika Therapeutics Inc.（US）
- LG Life Sciences, LTD（LG Chem）（South Korea）
- Bio plus Co. Ltd.（South Korea）
- Sculpt Luxury Dermal Fillers Ltd（UK）
- Bioxis Pharmaceutical（France）
- Sinclair Pharma（UK）
- Laboratories Vivacy（France）
- Bohus Biotech AB（Sweden）
- Croma-Pharma GmbH（Austria）
- Teoxane（Switzerland）
- Hyaltech Ltd.（Israel）
- Galatea Surgical（US）
- Medytox（South Korea）
- Suneva Medical（US）
- Laboratoires Filorga（France）
- Regen Lab SA（Switzerland）
Global Hyaluronic Acid Based Dermal Fillers Market size was valued at USD 4.22 billion in 2022 and is poised to grow from USD 4.60 billion in 2023 to USD 9.42 billion by 2031, growing at a CAGR of 9.10 % during the forecast period (2024-2031).
The surge in demand for non-invasive aesthetic procedures, coupled with a growing awareness of the versatile applications of Hyaluronic Acid (HA) in the beauty sector, is propelling market expansion. This momentum is further bolstered by increased investments in research and development for innovative dermal products and a rising trend of aesthetic procedures among men, who are increasingly mindful of the aging process's impact on their appearance. Technological advancements, exemplified by the introduction of laser resurfacing treatments in 2021, are revolutionizing the landscape by offering efficient solutions to various skin concerns with reduced invasiveness, meeting the demand for non-invasive techniques. Market leaders are prioritizing the development of advanced solutions to maintain a competitive edge, with a surge in new product approvals, including recent FDA approval for RHA Redensity, a groundbreaking dermal filler aimed at reducing wrinkles and lines. However, stringent government regulations in key markets like the U.S., European Union, and others present challenges, governing the development, branding, and production of HA-based products. Nonetheless, despite these obstacles, the global market is poised for significant growth, fueled by increasing demand for aesthetic procedures and ongoing technological innovations.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hyaluronic Acid Based Dermal Fillers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Hyaluronic Acid Based Dermal Fillers Market Segmental Analysis
A significant factor propelling the Global Hyaluronic Acid Based Dermal Fillers Market is the rising interest in non-invasive aesthetic treatments, spurred by heightened consumer awareness, a quest for youthful looks, and advancements in hyaluronic acid-based therapies. This surge in demand is not only stimulating market expansion but also presenting lucrative prospects for industry participants.
Drivers of the Global Hyaluronic Acid Based Dermal Fillers Market
Technological advancements stand as a paramount force propelling the Global Hyaluronic Acid Based Dermal Fillers Market forward. The ongoing progress in technology, encompassing breakthroughs in data analytics, artificial intelligence, and blockchain, has profoundly bolstered the expansion and efficacy of P2P lending platforms. These advancements have streamlined loan application procedures, fortified credit evaluation capacities, refined risk management frameworks, and delivered effortless user interactions for borrowers and lenders alike. Through the integration of cutting-edge technologies, the P2P lending sphere has broadened its outreach, rendering it more accessible, efficient, and attractive to a broader spectrum of participants.
Restraints in the Global Hyaluronic Acid Based Dermal Fillers Market
The elevated expense linked with surgical procedures stands as a significant impediment for the Global Hyaluronic Acid Based Dermal Fillers Market. Despite an increasing desire for aesthetic enhancements, the financial aspect poses a barrier for certain individuals, constraining their ability to avail themselves of such treatments. This cost factor could impede market expansion, particularly in areas where both affordability and accessibility remain key concerns for a substantial portion of the populace.
Market Trends of the Global Hyaluronic Acid Based Dermal Fillers Market
A notable market trend in the Global Hyaluronic Acid Based Dermal Fillers Market involves integrating lidocaine, a local anesthetic, into the fillers, with the goal of augmenting patient comfort during procedures by minimizing potential discomfort or pain. Numerous companies within the market have launched HA-based fillers containing lidocaine, acknowledging the significance of delivering a more pleasant experience for patients. This trend is in line with the increasing emphasis on enhancing patient satisfaction and refining treatment outcomes within the realm of aesthetic procedures.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Hyaluronic Acid Based Dermal Fillers Market by Product Type
- Market Overview
- Single phase and duplex products
Global Hyaluronic Acid Based Dermal Fillers Market by Application
- Market Overview
- Wrinkle correction
- lip augmentation
- rhinoplasty and others
Global Hyaluronic Acid Based Dermal Fillers Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Allergan (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Galderma Laboratories L.P. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merz Pharmaceuticals (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genzyme Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Anika Therapeutics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LG Life Sciences, LTD (LG Chem) (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio plus Co. Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sculpt Luxury Dermal Fillers Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioxis Pharmaceutical (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sinclair Pharma (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Laboratories Vivacy (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bohus Biotech AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Croma-Pharma GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teoxane (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hyaltech Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Galatea Surgical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medytox (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Suneva Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Laboratoires Filorga (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Regen Lab SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
